Its compounding-pathway status shifted in April 2026 when the FDA removed it from Category 2 of the 503A bulk substances list, though this is a compounding determination, not an approval
Phytochemical investigation and therapeutical potential of cotinus coggygria scop
Architectural and functional alterations of the small intestinal mucosa in classical Whipples disease
Puzzlingly, semaglutide (the active ingredient in Ozempic) has been FDA approved for weight loss under the brand name Wegovy
Dynamic Project Team: Assembling a team of internal experts tailored to your projects specific needs
Whether youre navigating hormonal shifts, recovering from a musculoskeletal challenge, or taking a preventive approach to aging, well help you stay strong, active, and mobile for years to come